CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Retinal transplantation instrument +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00346060
NCT00346060Phase 2Completed
CompareCT.gov

Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.

Radtke, Norman D., M.D.·interventional·Posted Jun 29, 2006·Updated Mar 13, 2014

In Brief

A Phase 2 clinical trial evaluating Retinal transplantation instrument and Fetal tissue. for Dry Age Related Macular Degeneration.. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The long-term goal is to show that retinal transplantation can help to prevent blindness and to restore eyesight in patients with dry age related macular degeneration.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Age Related Macular Degeneration.
CountriesUnited States
CollaboratorsFoundation Fighting Blindness

Timeline

Phase 2CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 29, 2006
Enrollment StartFeb 1, 2002
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 10.1 yearsPosted 20.0 years ago

Interventions

Retinal transplantation instrumentdevice

Fetal tissue.device